November 19, 2021 Third Time’s the Charm: The Fate of Skinny Labels May Hang in the Balance as Teva Tries Again at the Federal Circuit By Tasos Kanopoulos
November 17, 2021 Damned If We Don’t and… Also Damned If We Don’t: A Look into the History of Vaccine Mandates and the Future of the COVID-19 Vaccine By Eleesya Cordes
October 31, 2018 Government Legislation Calls for Greater Transparency in Drug Pricing By Tova Dardashty
October 22, 2018 Generic Copaxone Wins in Federal Circuit: Teva’s Patent Loss and Its Immediate Effects By Raina Duggirala